PH25854A - Transdermal therapeutical system comprising norpseudoephedrine as active component - Google Patents

Transdermal therapeutical system comprising norpseudoephedrine as active component

Info

Publication number
PH25854A
PH25854A PH39752A PH39752A PH25854A PH 25854 A PH25854 A PH 25854A PH 39752 A PH39752 A PH 39752A PH 39752 A PH39752 A PH 39752A PH 25854 A PH25854 A PH 25854A
Authority
PH
Philippines
Prior art keywords
norpseudoephedrine
active component
weight
therapeutical system
transdermal therapeutical
Prior art date
Application number
PH39752A
Other languages
English (en)
Inventor
Thomas Dr Hille
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of PH25854A publication Critical patent/PH25854A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PH39752A 1988-12-22 1989-12-20 Transdermal therapeutical system comprising norpseudoephedrine as active component PH25854A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3843237A DE3843237A1 (de) 1988-12-22 1988-12-22 Transdermales therapeutisches system mit einem antiadipositum als aktivem bestandteil

Publications (1)

Publication Number Publication Date
PH25854A true PH25854A (en) 1991-12-02

Family

ID=6369853

Family Applications (1)

Application Number Title Priority Date Filing Date
PH39752A PH25854A (en) 1988-12-22 1989-12-20 Transdermal therapeutical system comprising norpseudoephedrine as active component

Country Status (23)

Country Link
EP (1) EP0374725B1 (sv)
JP (1) JP2602108B2 (sv)
KR (1) KR950015055B1 (sv)
AT (1) ATE93147T1 (sv)
AU (1) AU614208B2 (sv)
CA (1) CA2006425C (sv)
CS (1) CS8907193A3 (sv)
DD (1) DD290581A5 (sv)
DE (2) DE3843237A1 (sv)
DK (1) DK651089A (sv)
ES (1) ES2045369T3 (sv)
FI (1) FI95772C (sv)
HU (1) HU203280B (sv)
IE (1) IE63878B1 (sv)
IL (1) IL92678A (sv)
MY (1) MY105074A (sv)
NO (1) NO178784C (sv)
NZ (1) NZ231909A (sv)
PH (1) PH25854A (sv)
PL (1) PL163292B1 (sv)
PT (1) PT92650B (sv)
YU (1) YU47075B (sv)
ZA (1) ZA899879B (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3939376C1 (sv) * 1989-11-29 1991-05-08 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg, 5450 Neuwied, De
DE4342893C2 (de) * 1993-12-16 1999-09-23 Lohmann Gmbh & Co Kg Reversibel haftende, rückstandsfrei wieder ablösbare Haftklebemasse, Verfahren zu deren Herstellung und Verwendung als wiederverklebbare Haftklebeartikel
US6602912B2 (en) 2000-06-30 2003-08-05 Dermatrends, Inc. Transdermal administration of phenylpropanolamine
US6719997B2 (en) 2000-06-30 2004-04-13 Dermatrends, Inc. Transdermal administration of pharmacologically active amines using hydroxide-releasing agents as permeation enhancers
JP2003528045A (ja) * 1999-12-16 2003-09-24 ダーマトレンズ, インコーポレイテッド フェニルプロパノールアミンの経皮投与
US6673363B2 (en) 1999-12-16 2004-01-06 Dermatrends, Inc. Transdermal and topical administration of local anesthetic agents using basic enhancers
KR100956865B1 (ko) * 2009-08-10 2010-05-11 주식회사 라이트론 슬라이드 가압패킹식 리니어 조명장치
WO2018081761A1 (en) * 2016-10-31 2018-05-03 The Corporation Of Mercer University Transdermal delivery of phenethylamine monoamine releasers

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
JPS57116011A (en) * 1981-01-08 1982-07-19 Nitto Electric Ind Co Ltd Pharmaceutical preparation
JPS60185713A (ja) * 1984-03-05 1985-09-21 Nitto Electric Ind Co Ltd 経皮吸収性製剤及びその製法
GB2156215B (en) * 1984-03-05 1988-03-02 Nitto Electric Ind Co Percutaneous absorption type adhesive pharmaceutical preparation
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
DE3629304A1 (de) * 1986-08-28 1988-03-24 Lohmann Gmbh & Co Kg Transdermales therapeutisches system, seine verwendung und verfahren zu seiner herstellung
DE3743945A1 (de) * 1987-09-01 1989-03-09 Lohmann Gmbh & Co Kg Vorrichtung zur abgabe von stoffen, verfahren zu ihrer herstellung sowie ihre verwendung

Also Published As

Publication number Publication date
HUT53517A (en) 1990-11-28
AU614208B2 (en) 1991-08-22
NZ231909A (en) 1991-06-25
NO178784C (no) 1996-06-05
PT92650A (pt) 1990-06-29
ES2045369T3 (es) 1994-01-16
IL92678A0 (en) 1990-09-17
PT92650B (pt) 1995-09-12
ZA899879B (en) 1990-09-26
YU47075B (sh) 1994-12-28
NO178784B (no) 1996-02-26
NO895173D0 (no) 1989-12-21
PL163292B1 (pl) 1994-03-31
FI95772C (sv) 1996-03-25
IL92678A (en) 1994-06-24
NO895173L (no) 1990-06-25
EP0374725B1 (de) 1993-08-18
JPH03123728A (ja) 1991-05-27
CA2006425C (en) 1995-09-05
KR900009063A (ko) 1990-07-02
DK651089D0 (da) 1989-12-20
CA2006425A1 (en) 1990-06-22
FI95772B (sv) 1995-12-15
IE894077L (en) 1990-06-22
EP0374725A3 (en) 1990-12-19
AU4684389A (en) 1990-06-28
ATE93147T1 (de) 1993-09-15
IE63878B1 (en) 1995-06-14
DE58905320D1 (de) 1993-09-23
JP2602108B2 (ja) 1997-04-23
CS275356B2 (en) 1992-02-19
YU240589A (en) 1991-04-30
HU203280B (en) 1991-07-29
HU896721D0 (en) 1990-02-28
DE3843237A1 (de) 1990-07-05
EP0374725A2 (de) 1990-06-27
DD290581A5 (de) 1991-06-06
FI896097A0 (sv) 1989-12-19
CS8907193A3 (en) 1992-02-19
DK651089A (da) 1990-06-23
KR950015055B1 (ko) 1995-12-21
MY105074A (en) 1994-07-30
DE3843237C2 (sv) 1991-04-11

Similar Documents

Publication Publication Date Title
MY105347A (en) Transdermal therapeutic system comprising as active component buprenorphine
PT92652A (pt) Processo para a preparacao de um sistema terapeutico transdermico contendo fisostigmina como ingrediente activo
IL92678A0 (en) Transdermal therapeutical system comprising norpseudoephedrine as active component